| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/21/2006 | WO2005107871A3 Pyrroloquinoline quinone drugs for treatment of cardiac injury |
| 12/21/2006 | US20060288434 Inhibiting angiogenesis in a mammal by administering an antibody which specifically binds to EphriniB2 or EphB4; cardiovascular disorders |
| 12/21/2006 | US20060287538 Process for the preparation of amorphous calcium salt of atorvastatin |
| 12/21/2006 | US20060287510 Crystallization of IGF-1 |
| 12/21/2006 | US20060287502 C3b/C4b complement receptor-like molecules and uses thereof |
| 12/21/2006 | US20060287389 Phenethanolamine derivatives for treatment of respiratory diseases |
| 12/21/2006 | US20060287374 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 12/21/2006 | US20060287368 Amide derivative of amlodipine |
| 12/21/2006 | US20060287346 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer |
| 12/21/2006 | US20060287340 e.g. 5-(4-fluorophenyl)-N-[2-(1-methyl-2-oxo-1,7-diazaspiro[4,4]nonan-7-yl)-6-quinolinyl]-2-pyrimidinecarboxamide; melanin concentrating hormone receptor antagonist; central nervous system disorders, cardiovascular disorders and metabolic disorders |
| 12/21/2006 | US20060287338 Metalloproteinase inhibitor compounds |
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 12/21/2006 | US20060287286 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 12/21/2006 | US20060287275 Using 5'-sulfoxyoxy adenosine in therapy for tachycardia, cardiovascular disorders, angina, myocardial infraction , antilipemic agents |
| 12/21/2006 | US20060287268 Splice-region antisense composition and method |
| 12/21/2006 | US20060287246 Remedy for eye diseases accompanied by optic nerve injuries |
| 12/21/2006 | US20060287235 Crystallization of IGF-1 |
| 12/21/2006 | US20060286179 Pharmeceutical composition comprising plant material or trichilia sp. alone or in association with other plant extracts for the reversion/combat and/or prevention of ventricular fibrillation |
| 12/21/2006 | US20060286150 Prevent menopause syndrome; therapy for skin aging; topical applying |
| 12/21/2006 | US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis |
| 12/21/2006 | US20060286088 Administration of enoxaparin sodium to patients 75 years and older with ST-segment elevation myocardial infarction |
| 12/21/2006 | US20060286077 Perivascular mesenchymal precursor cell induced blood vessel formation |
| 12/21/2006 | US20060286037 Heart-slowing drug containing short-acting ß blocker as the active ingredient |
| 12/21/2006 | DE202006012266U1 Natural healing and care oil, useful e.g. for treating wounds, joint pain and rheumatism, comprises extra virgin olive oil and tincture of propolis |
| 12/21/2006 | DE19843489B4 Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung Benzoylguanidine-derivatives having advantageous properties, to processes for their preparation and their use in the manufacture of medicinal products and pharmaceutical preparation containing them |
| 12/21/2006 | DE102005026762A1 Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen Azolopyridin-2-one derivatives as inhibitors of lipases, and phospholipases |
| 12/21/2006 | CA2612324A1 N-acyl derivatives of amino acids, a process for preparation thereof, a pharmaceutical composition and use thereof as antiallergic, anti-inflammatory and hypolipidemic agents |
| 12/21/2006 | CA2610903A1 N-(pyridin-2-yl)-sulfonamide derivatives |
| 12/21/2006 | CA2609938A1 New oxabispidine compounds for the treatment of cardiac arrhythmias |
| 12/21/2006 | CA2606351A1 Adamts13-comprising compositions having thrombolytic activity |
| 12/21/2006 | CA2596412A1 Anti-connexin compounds and uses thereof |
| 12/20/2006 | EP1734051A2 Composition and methods for the diagnosis of tumours |
| 12/20/2006 | EP1734041A2 Platelet ADP receptor inhibitors |
| 12/20/2006 | EP1734040A1 Substituted quinazoline or pyridopyrimidine derivative |
| 12/20/2006 | EP1734037A2 Processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol" |
| 12/20/2006 | EP1734031A1 Novel 2-(alpha-n-pentanonyl)benzoetes, their preparation and use |
| 12/20/2006 | EP1733733A1 Regulator for adiponectin receptor expression |
| 12/20/2006 | EP1733732A1 Insulin resistance improving agent |
| 12/20/2006 | EP1733729A1 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention |
| 12/20/2006 | EP1733728A2 Use of 2-alkoxyphenyl substituted imidazotriazinones as inhibitors of phosphodiesterase |
| 12/20/2006 | EP1733726A1 Pharmaceutically active isoindoline derivatives |
| 12/20/2006 | EP1733723A1 Medicine capable of inhibiting activation of transcription factor klf5 |
| 12/20/2006 | EP1733721A2 Use of astaxanthin or esters thereof as a phosphodiesterase inhibitor |
| 12/20/2006 | EP1732933A1 Compounds and methods for treating dyslipidemia |
| 12/20/2006 | EP1732929A1 Tricyclic benzopyran compound as anti-arrhythmic agents |
| 12/20/2006 | EP1732896A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp) |
| 12/20/2006 | EP1732574A1 The use of o-atp for the treatment of diseases involving angiogenesis |
| 12/20/2006 | EP1732565A1 Sustained-release oral molsidomine composition for treating atherosclerosis |
| 12/20/2006 | EP1732559A2 Methods of treatment using eszopiclone |
| 12/20/2006 | EP1732551A1 Perhexilin for treating chronic heart failure |
| 12/20/2006 | EP1732543A2 Tetra-cyclic carboline deratives for inhibiting angiogenesis |
| 12/20/2006 | EP1732537A1 Benzofuranyl derivatives useful for the treatment of cardiac arrhythmia |
| 12/20/2006 | EP1732534A1 Use of methylene amide derivatives in cardiovascular disorders |
| 12/20/2006 | EP1551822B1 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 12/20/2006 | EP1509501B1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 12/20/2006 | EP1506200B1 Diazabicyclic biaryl derivatives |
| 12/20/2006 | EP1474152B1 Orodispersible pharmaceutical composition comprising ivabradine |
| 12/20/2006 | EP1456171B1 Substituted cyclohexane derivatives |
| 12/20/2006 | EP1444329B1 Stem cells that transform to beating cardiomyocytes |
| 12/20/2006 | EP1441726B1 Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny]-valerian- acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors |
| 12/20/2006 | EP1401809B1 Tryptase inhibitors |
| 12/20/2006 | EP1390362B1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 12/20/2006 | EP1357903B1 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY|PHENOXY)-2-(4-METHOXYPHENYL) BENZO b|THIOPHENE AND SALTS THEREOF |
| 12/20/2006 | EP1353696B1 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 12/20/2006 | EP1343473B1 Pharmaceutical dronedarone composition for parenteral administration |
| 12/20/2006 | EP1263729B1 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 12/20/2006 | EP1202967B1 Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester |
| 12/20/2006 | EP1187816B1 5-cyano-2-aminopyrimidine derivatives |
| 12/20/2006 | EP1146891B1 Therapy of restenosis and atherosclerosis with a soluble vegf receptor and angiopoeitin-1 |
| 12/20/2006 | EP1135477B1 Humanized monoclonal integrin antibodies |
| 12/20/2006 | EP1131294B1 Quinoline derivatives as nk-2 and nk-3 receptor ligands |
| 12/20/2006 | CN1882687A Method of growing myocardial cells |
| 12/20/2006 | CN1882591A 5,7-diaminopyrazolo '4,3-d!pyrimidines with pde-5 inhibiting activity |
| 12/20/2006 | CN1882579A Substituted heteroaryl benzofuran acids |
| 12/20/2006 | CN1882538A Substituted sulfonamide-indole-2-carboxylic acid derivatives as PAI-1 inhibitors |
| 12/20/2006 | CN1882532A Aminoalkylamide substituted cyclohexyl derivatives |
| 12/20/2006 | CN1882350A Method for controlling angiogenesis in animals |
| 12/20/2006 | CN1882331A Tubular proteinuria as an indicator for elevated cardiovascular risk |
| 12/20/2006 | CN1882312A Methods of preparing a foam comprising a sclerosing agent |
| 12/20/2006 | CN1882311A Methods of preparing a foam comprising a sclerosing agent |
| 12/20/2006 | CN1880328A Preparation method of hyperin and hypericin of Hypericum perforatum |
| 12/20/2006 | CN1880306A Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 12/20/2006 | CN1880304A Triamide-substituted indoles, benzofuranes and benzothiophenes |
| 12/20/2006 | CN1879886A Sodium acetylide/ soybean separation protein commixed gel granule preparation method |
| 12/20/2006 | CN1879884A Synergistic therapeutic compositions and methods |
| 12/20/2006 | CN1879851A Quality detection method of a compound Chinese medicine |
| 12/20/2006 | CN1879840A A nano 'Xing Nao Jing' injection and method for preparing same |
| 12/20/2006 | CN1879810A A medicine for treating vertebrobasilar insufficiency and method for preparing same |
| 12/20/2006 | CN1879792A A Chinese medicinal preparation for treating hypertension and cerebrovascular disease |
| 12/20/2006 | CN1879774A Soft capsule of 'Sheng Mai' and method for preparing same |
| 12/20/2006 | CN1879768A Mind tranquilizing medicine |
| 12/20/2006 | CN1879767A Mind tranquilizing medicine |
| 12/20/2006 | CN1879760A Compound medicine for treating high paralysis, fracture sequelae, cardiac infarction and splenomegaly |
| 12/20/2006 | CN1879726A Medicine for treating piles |
| 12/20/2006 | CN1879714A A Chinese medicinal composition for treating thrombus |
| 12/20/2006 | CN1879709A Chinese medicine for treating piles and anal fistula |
| 12/20/2006 | CN1879692A Novel use of camphor tree in toxin expelling, detoxication, cancer prevention, cancer resistance and beauty treatment |
| 12/20/2006 | CN1879678A Medicinal pills for treating rheumatism |
| 12/20/2006 | CN1879675A A method for extracting effective parts to treat cardiovascular and cerebraovascular diseases |
| 12/20/2006 | CN1879653A Bezoar nano-powder preparation process and pharmaceutical preparation thereof |